Elicio Therapeutics, Inc. (NASDAQ:ELTX) IPO
IPO
Went public as Angion Biomedica Corp. Priced at US$16.00 a share on Feb 4, 2021.
- Price
- US$16.00 a share
- Shares offered
- 5,000,000 shares of common stock
- Offering size
- US$80 million
- Underwriters' option
- Up to 750,000 more shares
- Listing
- ANGN on the Nasdaq Global Select Market
- Underwriters
- Cowen, Stifel, H.C. Wainwright & Co., Oppenheimer & Co. · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Feb 14, 2020 |
| Filed publicly | Jan 15, 2021 |
| Amended twice | Newest Feb 4, 2021 |
| Shares registered with an exchange | Feb 2, 2021 |
| Declared effective by the SEC | Feb 4, 2021 |
| Final prospectus, with the price | Feb 5, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Feb 5, 2021 |
| EFFECT · Notice that a registration is effective | Feb 4, 2021 |
| CERT · Exchange's certificate of listing | Feb 4, 2021 |
| 8-A12B/A · Registration of shares for listing on an exchange, amended | Feb 4, 2021 |
| S-1/A · Registration statement, amended | Feb 4, 2021 |
| CORRESP · Letter to the SEC | Feb 2, 2021 |
| CORRESP · Letter to the SEC | Feb 2, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Feb 2, 2021 |
| S-1/A · Registration statement, amended | Feb 1, 2021 |
| CORRESP · Letter to the SEC | Jan 26, 2021 |
| CORRESP · Letter to the SEC | Jan 15, 2021 |
| S-1 · Registration statement | Jan 15, 2021 |
| UPLOAD · Letter from the SEC | Dec 18, 2020 |
| DRSLTR · Letter to the SEC with a draft | Dec 15, 2020 |
| DRS/A · Draft registration statement, amended | Dec 15, 2020 |
| UPLOAD · Letter from the SEC | May 27, 2020 |
| DRSLTR · Letter to the SEC with a draft | May 13, 2020 |
| DRS/A · Draft registration statement, amended | May 13, 2020 |
| UPLOAD · Letter from the SEC | Mar 10, 2020 |
| DRS · Draft registration statement | Feb 14, 2020 |
From the cover of the final prospectus (424B4) filed Feb 5, 2021